Edwards Lifesciences
1,298 hedge funds and large institutions have $43B invested in Edwards Lifesciences in 2025 Q4 according to their latest regulatory filings, with 176 funds opening new positions, 418 increasing their positions, 474 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
12% less repeat investments, than reductions
Existing positions increased: 418 | Existing positions reduced: 474
17% less call options, than puts
Call options by funds: $336M | Put options by funds: $407M
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Holders
1,298
Holding in Top 10
8
Calls
$336M
Puts
$407M
Top Buyers
| 1 | +$353M | |
| 2 | +$194M | |
| 3 | +$164M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$121M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$104M |
Top Sellers
| 1 | -$239M | |
| 2 | -$205M | |
| 3 | -$167M | |
| 4 |
BlackRock
New York
|
-$150M |
| 5 |
Bank of New York Mellon
New York
|
-$125M |
